Javascript must be enabled to continue!
Retrovirus D/New England and its relation to Mason-Pfizer monkey virus
View through CrossRef
Seventeen isolates of retrovirus D/New England have been obtained from three species of macaques at the New England Regional Primate Research Center. Seven of the isolates were obtained from macaques who subsequently died with the macaque immunodeficiency syndrome; other isolates were obtained from macaques with less severe or other forms of illness. Attempts to isolate type D retrovirus from peripheral lymphocytes of 97 apparently healthy macaques have not been successful. Cloned DNA was prepared from Hirt supernatants of cells infected with one of these isolates (D/New England 398). By restriction endonuclease analysis, cloned pD398 DNA represented full-length viral DNA with one long terminal repeat. A detailed restriction endonuclease map of pD398 was derived and compared with a map of the cloned Mason-Pfizer monkey virus genome. Forty-six percent (13 of 28) of restriction endonuclease sites were found to be conserved when these related viruses were compared. Five of the D/New England isolates, including those from three different macaque species, were examined for strain variability by restriction endonuclease typing. Comparison of over 30 restriction endonuclease sites has not distinguished any of these D/New England isolates. It thus appears that a single strain of type D retrovirus is infecting three different species of macaques in the New England colony. Markedly reduced cross-hybridization was observed between cloned pD398 and Mason-Pfizer monkey virus DNAs at high stringency; this reduced cross-hybridization was localized to the pol-env regions of the genome. Only very weak hybridization of D/New England DNA to cloned squirrel monkey type D retrovirus DNA could be detected even at low-stringency conditions. What role type D retrovirus plays in the immunodeficiency syndrome of macaques remains to be determined.
American Society for Microbiology
Title: Retrovirus D/New England and its relation to Mason-Pfizer monkey virus
Description:
Seventeen isolates of retrovirus D/New England have been obtained from three species of macaques at the New England Regional Primate Research Center.
Seven of the isolates were obtained from macaques who subsequently died with the macaque immunodeficiency syndrome; other isolates were obtained from macaques with less severe or other forms of illness.
Attempts to isolate type D retrovirus from peripheral lymphocytes of 97 apparently healthy macaques have not been successful.
Cloned DNA was prepared from Hirt supernatants of cells infected with one of these isolates (D/New England 398).
By restriction endonuclease analysis, cloned pD398 DNA represented full-length viral DNA with one long terminal repeat.
A detailed restriction endonuclease map of pD398 was derived and compared with a map of the cloned Mason-Pfizer monkey virus genome.
Forty-six percent (13 of 28) of restriction endonuclease sites were found to be conserved when these related viruses were compared.
Five of the D/New England isolates, including those from three different macaque species, were examined for strain variability by restriction endonuclease typing.
Comparison of over 30 restriction endonuclease sites has not distinguished any of these D/New England isolates.
It thus appears that a single strain of type D retrovirus is infecting three different species of macaques in the New England colony.
Markedly reduced cross-hybridization was observed between cloned pD398 and Mason-Pfizer monkey virus DNAs at high stringency; this reduced cross-hybridization was localized to the pol-env regions of the genome.
Only very weak hybridization of D/New England DNA to cloned squirrel monkey type D retrovirus DNA could be detected even at low-stringency conditions.
What role type D retrovirus plays in the immunodeficiency syndrome of macaques remains to be determined.
Related Results
P0672 Persistence of Vedolizumab after switching to the subcutaneous route: results from the national French cohort study DOPER
P0672 Persistence of Vedolizumab after switching to the subcutaneous route: results from the national French cohort study DOPER
Abstract
Background
Vedolizumab (VDZ) has been available in France as a subcutaneous formulation for the treatment of inf...
SARS-CoV-2 infection rates after different vaccination schemes
SARS-CoV-2 infection rates after different vaccination schemes
Objective:
To identify effects of various nationwide vaccination protocols on the evolution of new SARS-CoV-2 infections among adult population and to evaluate the safe...
A Novel Non-Covalent Modulator of Hemoglobin Improves Anemia and Reduces Sickling in a Mouse Model of Sickle Cell Disease
A Novel Non-Covalent Modulator of Hemoglobin Improves Anemia and Reduces Sickling in a Mouse Model of Sickle Cell Disease
Sickle cell disease (SCD) is a severe genetic disorder caused by a single point mutation on the β-chain of adult hemoglobin (Hb A), β6 Glu→Val (Hb S). In the deoxygenated state Hb ...
Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin
Early Comparison of Major Bleeding, Stroke and Associated Medical Costs Among Treatment-Naive Non-Valvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban or Warfarin
INTRODUCTION: Recent large randomized controlled trials have shown that novel oral anticoagulants (NOACs) are at least as effective as warfarin for risk reduction of stroke or syst...
P-611. Time-Series Model Estimation of Respiratory Syncytial Virus-Attributable Respiratory Hospitalizations and Mortality in Adults in Finland
P-611. Time-Series Model Estimation of Respiratory Syncytial Virus-Attributable Respiratory Hospitalizations and Mortality in Adults in Finland
Abstract
Background
As in other countries, respiratory syncytial virus (RSV) incidence among adults in Finland is still u...
P-680. Estimated Respiratory Syncytial Virus (RSV)-Related Hospitalizations and Deaths among Adults in Norway between 2010–2019
P-680. Estimated Respiratory Syncytial Virus (RSV)-Related Hospitalizations and Deaths among Adults in Norway between 2010–2019
Abstract
Background
RSV can trigger acute cardiac events and cause respiratory disease in adults, but the true burden of RSV-ass...
16. A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States
16. A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States
Abstract
Background
Because of the number and variability of serotypes causing pneumococcal disease among different geographic r...

